Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +1.90% | +10.91% | -59.61% |
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 04/07/13 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 30/09/15 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Stephan Toutain
COO | Chief Operating Officer | - | 04/03/18 |
David Goldberger
LAW | General Counsel | - | 11-05 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 04/05/21 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 31/08/15 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 04/07/13 | |
Tom Skarpelos
FOU | Founder | 57 | 22/01/04 |
Jiong Ma
CHM | Chairman | 60 | 24/05/21 |
Steffen Thomas
BRD | Director/Board Member | 58 | 14/06/15 |
Peter Donhauser
BRD | Director/Board Member | 58 | 07/02/17 |
Director/Board Member | 51 | 01/03/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,112,511 | 79,530,715 ( 96.86 %) | 0 | 96.86 % |
Company contact information
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.61% | 303M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- AVXL Stock
- Company Anavex Life Sciences Corp.